Invention Application
- Patent Title: COMPOUNDS AND THERAPEUTICAL USE THEREOF
- Patent Title (中): 化合物及其治疗用途
-
Application No.: US11773303Application Date: 2007-07-03
-
Publication No.: US20080004297A1Publication Date: 2008-01-03
- Inventor: Sui Cai , Mark Anderson , Adam Willardsen , Nilantha Sirisoma , Hong Zhang , Kazuyuki Suzuki
- Applicant: Sui Cai , Mark Anderson , Adam Willardsen , Nilantha Sirisoma , Hong Zhang , Kazuyuki Suzuki
- Applicant Address: US UT Salt Lake City US CA San Diego
- Assignee: Myriad Genetics, Inc.,Cytovia, Inc.
- Current Assignee: Myriad Genetics, Inc.,Cytovia, Inc.
- Current Assignee Address: US UT Salt Lake City US CA San Diego
- Main IPC: A61K31/517
- IPC: A61K31/517 ; A61P31/10 ; A61P31/12 ; A61P35/00 ; A61P37/00 ; C07D239/84 ; C07D239/94 ; C07D401/12 ; C07D403/12
Abstract:
Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
Public/Granted literature
Information query
IPC分类:
